JordanMatthewDunitzMD
Pulmonology • Minneapolis, MNCritical Care Medicine, Cystic Fibrosis, Lung Transplantation Medicine, Pleural Disease
UMPhysicians
Dr. Dunitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
University of Minnesota Physicians
516 Delaware Street SE PWB Second floor Clinic 2a
Minneapolis, MN 55455Phone+1 612-626-6100Fax+1 612-625-2174
Education & Training
University of MinnesotaFellowship, Pulmonary Disease and Critical Care Medicine, 1991 - 1994- University of MinnesotaResidency, Internal Medicine, 1988 - 1991
Stony Brook University Health Sciences Center School of MedicineClass of 1988
Certifications & Licensure
MN State Medical License 1993 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Effects of an Antioxidant-Enriched Multivitamin Supplement on Inflammation and Oxidative Stress in Cystic Fibrosis Start of enrollment: 2013 Jun 01
- Mapping Chemical and Microbiological Heterogeneity Throughout Explanted Cystic Fibrosis Lung Specimens Start of enrollment: 2014 Jul 01
Publications & Presentations
PubMed
- A national postgraduate nurse practitioner and physician assistant fellowship in cystic fibrosis: An innovative approach to the provider shortage in complex and rare d...Cynthia J Brady, Wendy S Looman, Jennifer L Hamilton, Jordan Dunitz, Taylor Gilard
Journal of the American Association of Nurse Practitioners. 2024-09-01 - Attitudes toward and preparedness for lung transplantation among individuals with cystic fibrosis in the era of highly effective modulators.Nora Burdis, Siddhartha G Kapnadak, Lauren E Bartlett, Oliver McElvaney, Tijana Milinic
BMC Pulmonary Medicine. 2024-07-18 - Seroprevalence of SARS-CoV-2 IgG in people with cystic fibrosis.Kathleen Mahan, Sarah Kiel, Rebecca Freese, Nicholas Marka, Jordan Dunitz
Heliyon. 2024-03-30
Press Mentions
New FDA-Approved Treatment for Cystic Fibrosis Gives Hope to ThousandsOctober 22nd, 2019
Grant Support
- A Phase 3, International, Multi-Center, Randomized, Double-Blind, Placebo-ControNational Center For Research Resources2009
- A Phase 2A, Randomized, Double-Blind, Placebo-Controlled Study Of VX-770 To EvalNational Center For Research Resources2008–2009
- 08-108: Denufosol Tetrasodium Inhalatoin Solution In Mild CF Lung DiseaseNational Center For Research Resources2007–2009
- A Phase 1, OPEN Label Safety And Tolerability Study Of Oral Theraclec In SubjectNational Center For Research Resources2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
